|
|
|
In October 2007, the FDA approved the drug ixabepilone Ixempra; Bristol Myers Squibb, Princeton, NJ for the treatment of advanced breast cancer in patients whose tumors are unresponsive to other types of chemotherapy <a href=https://fastpriligy.top/>priligy amazon uk</a> |
|
发表于